跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BAT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BAT
Authorized
STANDARD
BAT
Emergent Biosolutions Canada Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
54c565b93450890b
Company
Emergent Biosolutions Canada Inc.
Type
Standard
Approval Details
Approval Id
54c565b93450890b
Drug Approval Canada Name
BAT
Product Name
BAT
Status
Restricted Access
Status Date
2017-10-25
Din
02459612
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
80:04.00
Atc Original
J06AA04 BOTULINUM ANTITOXIN
Atc Name
j 06 aa 04
Aig Number
0758630001
Company Name
Emergent Biosolutions Canada Inc.
Company Address
155 Innovation Drive, Winnipeg, Manitoba, Canada, R3T 5Y3
Company Detail Path
/organization/emergent-biosolutions-canada-inc
Company Information
Pharmaceutical Company Name
Emergent Biosolutions Canada Inc.
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
100 King St W
Active Ingredients
BOTULINUM ANTITOXIN SEROTYPE D
600 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE B
3300 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE F
3000 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE G
600 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE A
4500 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE C
3000 UNIT / VIAL
BOTULINUM ANTITOXIN SEROTYPE E
5100 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
54c565b93450890b
Type
Standard
Back to Health Canada Approvals